2002
DOI: 10.1016/s0140-6736(02)11201-3
|View full text |Cite
|
Sign up to set email alerts
|

Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

4
375
1
8

Year Published

2005
2005
2015
2015

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 452 publications
(388 citation statements)
references
References 27 publications
4
375
1
8
Order By: Relevance
“…In addition, a lack of cathelicidin and other antimicrobial peptides correlates with increased infections in patients with atopic dermatitis or Kostman syndrome (19,35). These observations provide compelling evidence that cathelicidins act as innate antibiotics to kill or inhibit microbes.…”
Section: Discussionmentioning
confidence: 93%
“…In addition, a lack of cathelicidin and other antimicrobial peptides correlates with increased infections in patients with atopic dermatitis or Kostman syndrome (19,35). These observations provide compelling evidence that cathelicidins act as innate antibiotics to kill or inhibit microbes.…”
Section: Discussionmentioning
confidence: 93%
“…The sAMPs play a pivotal role in maintaining mucosal immune integrity (Allgrove et al 2008;Bals and Hiemstra 2004;Papacosta and Nassis 2011;West et al 2006) by working synergistically to curtail invading bacteria, viruses, and fungi (De Smet and Contreras 2005;Radek and Gallo 2007;West et al 2006) and are vital in both the prevention and clearance of many types of infection (Bowdish et al 2005;Davison et al 2009;West et al 2006). In particular, infections of the oral cavity and upper respiratory tract (URTI) are associated with depressed levels of sAMPs (Table 1) (Bartlett et al 2008;Bishop and Gleeson 2009;Dale et al 2006;Doss et al 2010;Laube et al 2006;Putsep et al 2002;Tanida et al 2003;Tao et al 2005;Ueta et al 2000;West et al 2006), highlighting their prominent role in first--line immune defense.…”
Section: Introductionmentioning
confidence: 99%
“…The only known cathelicidin peptide expressed in humans is LL-37, a 37-aa C-terminal domain of human (h)CAP-18 (4). The importance of cathelicidins as an effective defense against pathogenic microorganisms is illustrated by the high occurrence of periodontal disease in patients with severe congenital neutropenia accompanied by a deficiency of LL-37 in saliva (5), as well as an animal study showing severe bacterial skin infections in mice lacking murine cathelicidin-related CAPs (6). Overexpression of hCAP-18 after pulmonary gene transfer in mice results in increased Pseudomonas aeruginosa clearance in the course of pulmonary challenge (7).…”
mentioning
confidence: 99%